Buyer Database · Buyer / Distributor · Updated
New Line Cinema
New Line Cinema is operating as Warner Bros.' horror engine in 2025, with four genre releases combining for $768 million worldwide and a pipeline extending into franchise sequels and co-produced originals through 2026.
Current mandate
New Line Cinema is currently the horror-focused label within the Warner Bros. theatrical ecosystem, accounting for roughly 20% of Warner Bros.' $3.7 billion global box office since January 2025 on the strength of four genre releases: "Companion," "Final Destination: Bloodlines," "Weapons," and "The Conjuring: Last Rites." The label's most recent landmark is "The Conjuring: Last Rites," which opened to $84 million domestic and $194 million globally, placing New Line alongside its own "It" (2017) and "It: Chapter Two" in the top three highest horror openings in box office history. "Weapons," acquired against a $38 million all-in budget, has grossed $251.5 million worldwide after five weekends.
Over the past 12 months, New Line has demonstrated a consistent pattern of backing horror at a range of budget levels, from lower-cost originals to established franchise entries, and marketing each with distinct campaign strategies. Mystery-driven pitches have been deployed for original horror such as "Weapons," final-chapter positioning for "Last Rites," and nostalgia and viral stunts for "Final Destination: Bloodlines." The label has also leaned on early September and the Labor Day weekend as a recurring theatrical launchpad, targeting teens and young adults returning to school. Co-production partnerships, notably with Blumhouse and Atomic Monster, are a visible part of the acquisition and development strategy, as seen with the upcoming "Evil Dead Burn" and Lee Cronin's "The Mummy."
Filmmakers and representatives seeking access to New Line should approach through established genre producers and co-production partners already in the Warner Bros. orbit. The label's upcoming slate, including "Mortal Kombat II" dated for May 2026, signals continued appetite for franchise IP alongside original horror. Decision-maker tracking across the broader Warner Bros. system is active, with 53 contacts logged in recent coverage.
Signature peaks
- $251.5M Weapons Worldwide Gross — After five weekends against a $38M all-in budget
- $194M Conjuring: Last Rites Global Opening — Domestic opening of $84M; top-three horror opening in box office history alongside It (2017) and It: Chapter Two
- 53 Decision Makers Tracked — Contacts logged across New Line and Warner Bros. distribution leadership in recent coverage
Mandate dimensions
- Genre focus
- horror, comedy, action, thriller
- Territory focus
- Not disclosed
- Budget tier (observed)
- Not disclosed
- Access pattern
- Access runs primarily through established genre producers and co-production partners within the Warner Bros. orbit. Blumhouse and Atomic Monster are documented co-production partners on upcoming New Line releases, making them viable intermediary entry points. Agency representation with existing Warner Bros. relationships is the standard channel. The label does not publicize open submissions.
- Deal structure
- New Line operates on a co-production and acquisition model, with recent deals spanning outright acquisitions (such as "Companion" and "Weapons," both at undisclosed prices) and co-productions with partners including Blumhouse and Atomic Monster. Budget levels range from lower-cost originals (documented as low as a $38 million all-in budget for "Weapons") to higher-cost franchise sequels. Specific acquisition prices are not disclosed in available records.
Recent acquisitions
-
Companion
-
Weapons
Market context
"New Line is an essential partner. Their ability to tap into the zeitgeist more than anyone is extraordinary. They have the special sauce and they understand horror." — Jeff Goldstein, Warner Bros. distribution chief
New Line Cinema is currently the horror-focused label within the Warner Bros. theatrical ecosystem, accounting for roughly 20% of Warner Bros.' $3.7 billion global box office since January 2025 on the strength of four genre releases: "Companion," "Final Destination: Bloodlines," "Weapons," and "The Conjuring: Last Rites." The label's most recent landmark is "The Conjuring: Last Rites," which opened to $84 million domestic and $194 million globally, placing New Line alongside its own "It" (2017) and "It: Chapter Two" in the top three highest horror openings in box office history. "Weapons," acquired against a $38 million all-in budget, has grossed $251.5 million worldwide after five weekends.
Common questions about New Line Cinema
Does New Line Cinema accept unsolicited scripts?
New Line Cinema does not have a publicized open-submission policy and operates as a label within Warner Bros., where material typically moves through established producer relationships and agency channels. Recent acquisitions such as 'Companion' and 'Weapons' came through producer and co-production pipelines rather than open calls. Writers without representation are best served by attaching a producer already working within the Warner Bros. or New Line ecosystem, including co-production partners such as Blumhouse and Atomic Monster, which have active deals with the label.
What budgets does New Line Cinema work with for horror films?
New Line's 2025 slate demonstrates comfort across a meaningful budget range. 'Weapons' carried a $38 million all-in budget and is cited as a lower-cost original. Franchise entries such as 'The Conjuring: Last Rites' and 'Final Destination: Bloodlines' operate at higher price points consistent with established IP. The label also co-produces with Blumhouse, which is known for tighter budget discipline, suggesting New Line can accommodate projects well below the $38 million marker when the concept and partners are right.
Does New Line Cinema acquire films at festivals?
No specific festival acquisition is documented in recent coverage of New Line's 2025 activity. The label's tracked acquisitions, including 'Companion' and 'Weapons,' do not carry festival-origin sourcing in available records. New Line's model appears oriented toward development and co-production deals rather than festival floor pickups, though the broader Warner Bros. system does monitor festival markets. Filmmakers premiering genre work at major festivals should ensure their sales agent has Warner Bros. and New Line contacts engaged ahead of any premiere.
How do you reach New Line Cinema decision makers?
According to recent coverage, 53 decision makers are tracked across New Line and the Warner Bros. distribution and production apparatus. The most direct documented pathway runs through established genre producers and co-production partners already aligned with the label, particularly Blumhouse and Atomic Monster, both of which have active co-production credits on upcoming New Line releases. Warner Bros. distribution chief Jeff Goldstein is publicly identified as a key voice on New Line's theatrical strategy. Representation by a major agency with existing Warner Bros. relationships is the standard access route.
What genres is New Line Cinema focused on right now?
Horror is New Line's primary and most publicly stated focus in 2025. Jeff Goldstein, Warner Bros. distribution chief, has described New Line as having 'the special sauce' in horror, and the label's four 2025 releases, 'Companion,' 'Final Destination: Bloodlines,' 'Weapons,' and 'The Conjuring: Last Rites,' are all genre titles. The upcoming slate includes 'Evil Dead Burn,' Lee Cronin's 'The Mummy,' and 'Mortal Kombat II,' indicating continued appetite for horror and action-franchise IP. Original horror with a distinct high-concept hook, as seen with 'Weapons,' appears particularly attractive alongside established franchise sequels.
Is New Line Cinema currently active in acquisitions?
New Line's most recent tracked acquisitions, 'Companion' and 'Weapons,' were logged in early 2023, and no new deals are recorded in the 30- or 90-day windows per current activity metrics. However, the label's deal velocity signal remains active as of late June 2026, and its upcoming slate through 2026, including 'Mortal Kombat II' (May 2026), 'Evil Dead Burn,' and Lee Cronin's 'The Mummy,' confirms ongoing production and co-production commitments. The label appears to be in a slate-execution phase rather than an open-acquisition window at present, according to available records.
Adjacent buyers in this lane
- Focus Features — Focus Features is doubling down on experiential brand-building and festival acquisitions to court th
- Roadside Attractions — Roadside Attractions is a North American boutique distributor actively acquiring festival-originated
- Fox Entertainment — Fox Entertainment is running a deliberate, low-volume acquisition strategy built around creator-led,
- 20th Television — 20th Television is actively building its overall-deal roster and deepening its animation pipeline, w
Related reading
Match your script to New Line Cinema
This is a public snapshot of New Line Cinema, kept current from trade-press signals. Inside ScriptMatch, upload your script to see whether New Line Cinema fits, why, and exactly how to reach them. Start a free 7-day trial or try the free buyer-match tool.